Park West Asset Management LLC Reduces Stock Position in LENSAR, Inc. (NASDAQ:LNSR)

Park West Asset Management LLC lessened its holdings in LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 18.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 810,676 shares of the company's stock after selling 179,269 shares during the quarter. Park West Asset Management LLC owned approximately 6.98% of LENSAR worth $7,247,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of LNSR. Brandes Investment Partners LP increased its holdings in LENSAR by 10.4% in the fourth quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock valued at $4,375,000 after buying an additional 45,920 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of LENSAR by 13.3% in the 4th quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after purchasing an additional 40,946 shares during the period. Bailard Inc. acquired a new position in LENSAR during the fourth quarter worth approximately $181,000. Evernest Financial Advisors LLC purchased a new stake in LENSAR in the fourth quarter valued at approximately $174,000. Finally, Essex Investment Management Co. LLC lifted its stake in LENSAR by 18.3% in the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after buying an additional 6,184 shares during the last quarter. Hedge funds and other institutional investors own 40.15% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on LNSR. Lake Street Capital reiterated a "hold" rating and issued a $15.00 price objective (down previously from $16.00) on shares of LENSAR in a research note on Monday, March 24th. BTIG Research cut LENSAR from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 24th.

LENSAR Trading Up 0.9 %

NASDAQ:LNSR opened at $14.03 on Tuesday. The firm has a market cap of $165.40 million, a P/E ratio of -9.61 and a beta of 0.56. The stock's 50 day simple moving average is $13.62 and its 200-day simple moving average is $9.98. LENSAR, Inc. has a 12-month low of $2.95 and a 12-month high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported ($1.61) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($1.40). The company had revenue of $16.73 million during the quarter, compared to analyst estimates of $14.95 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.